Elder Pharmaceuticals (Delisted) share price
BSE: 532322
Elder Pharmaceuticals Ltd · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary
Last traded ₹38.00 on 12 Sep 2016
Delisted on 11 May 2018.
Last announcements
The company's own last announcements before its shares stopped trading, routine notices left out.
May 2018
Feb 2018
Jun 2017
5 Jun · Legal
Exchange has sought clarification from Elder Pharmaceuticals Ltd with respect to news article appearing on business-standard.com on June 2, 2017 titled "Elder Pharma files for insolvency." ....5 Jun · Legal
Exchange has sought clarification from the Company with respect to news item captioned "Elder Pharma files for Insolvency". In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is awaited.
Jul 2016
21 Jul · Legal
Exchange has sought clarification from Elder Pharmaceuticals Ltd with respect to news article appearing on Moneylife on July 21, 2016 titled "Elder Pharma, embroiled in bribery case, ....21 Jul · Legal
Exchange has sought clarification from Elder Pharmaceuticals Limited with respect to recent news item captioned 'Elder Pharma, embroiled in bribery case, is among the biggest defaulters and the Ministry is doing nothing'. In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company are aware of any information that has not been announced to the Exchanges under regulation 30 of Listing regulations. The response from the Company is awaited.
Results for the quarter to Mar 2015
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
- RevenueRevenue from operations. Money earned from selling the company's goods and services in the period. Revenue from operations in the glossary
- ₹24 Cr−76.0% on a year ago · −31.4% on the quarter beforeChange on a year ago and on the quarter before. The change against the same quarter a year before: (this quarter's figure less that quarter's) divided by that quarter's, times 100. The change on the quarter before is the same sum against the quarter just before, taken as this quarter's results restate it where the company restated it: this quarter's year to date less this quarter. Left out where either figure is a loss, where the restatement covers two or more earlier quarters without saying which, or across a change of basis named under the table, on the lines it affects.
- Operating profitOperating profit before depreciation (EBITDA). Revenue less operating expenses: what the business earns from its operations before depreciation, interest and tax. Operating profit before depreciation (EBITDA) in the glossary
- −₹23 Cr
- Net profitNet profit. What is left of revenue and other income after every cost, interest and tax. Net profit in the glossary
- −₹51 Cr
- Earnings per shareEarnings per share. Profit belonging to shareholders divided by the number of shares, restated for later splits and bonuses so they do not break the line. Earnings per share in the glossary
- −₹24.93
- Operating margin
- −93.6%
- Net margin
- −210.0%
From revenue to net profit, ₹ crore
- Revenue24
- Materials and goods−25
- Employee costs−12
- Other expenses−10
- Operating profit−23
- Depreciation−7.9
- Other income+1.1
- Finance costs−22
- Profit before tax−51
- Net profit−51
Elder Pharmaceuticals results by quarter
Standalone: the listed company alone, without its subsidiaries. Latest quarter to Mar 2015. Results for the quarter to Jun 2015 were due by 29 Aug 2015, 60 days after it ends. Every company's dates are on the results calendar.
Revenue and net profit by quarter, ₹ crore
- Revenue
- Net profit
- Loss
Peak revenue ₹303 Cr, quarter to Sep 2012; lowest ₹24 Cr, quarter to Mar 2015A loss in 5 of the 11 quarters with results on record
Operating and net margin by quarter, per cent
- Operating margin
- Net margin
| ₹ crore | Jun 2010 | Sep 2010 | Dec 2010 | Mar 2011 | Jun 2011 | Sep 2011 | Dec 2011 | Mar 2012 | Jun 2012 | Sep 2012 | Dec 2012 | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 191 | 204 | 210 | 222 | 224 | 253 | 257 | 244 | 260 | 303 | 251 | – | 189 | 153 | 138 | 102 | 91 | 84 | 36 | 24 |
| Operating expenses. What the business spent to run itself in the period, materials, staff and other costs, before depreciation, interest and tax. Operating expenses in the glossary | 152 | 161 | 165 | 173 | 171 | 199 | 201 | – | 204 | 242 | 196 | – | 131 | – | 111 | 115 | 233 | 110 | 67 | 47 |
| Materials and goods boughtCost of materials and goods. Raw materials used and goods bought for resale in the period, adjusted for the change in stock held. Cost of materials and goods in the glossary | 89 | 98 | 100 | 103 | 103 | 117 | 134 | 107 | 123 | 151 | 101 | – | 63 | 59 | 57 | 45 | 146 | 67 | 38 | 25 |
| Employee costsEmployee costs. Salaries, wages, bonuses and other benefits paid to staff in the period. Employee costs in the glossary | 25 | 27 | 27 | 27 | 27 | 31 | 32 | – | 29 | 34 | 35 | – | 31 | – | 26 | 30 | 34 | 16 | 15 | 12 |
| Other expensesOther expenses. Every operating cost besides materials and staff: power, rent, freight, repairs, marketing and the like. Other expenses in the glossary | 37 | 36 | 38 | 44 | 40 | 50 | 35 | – | 52 | 57 | 61 | – | 37 | – | 27 | 39 | 52 | 27 | 14 | 10 |
| Operating profit before depreciation | 40 | 44 | 45 | 49 | 53 | 54 | 56 | – | 56 | 61 | 54 | – | 58 | – | 27 | −13 | −142 | −26 | −32 | −23 |
| Operating margin | 20.7% | 21.4% | 21.2% | 21.9% | 23.6% | 21.5% | 21.7% | – | 21.5% | 20.0% | 21.7% | – | 30.6% | – | 19.4% | −13.2% | −156.4% | −30.4% | −89.1% | −93.6% |
| Depreciation and amortisationDepreciation and amortisation. The part of the cost of plant, buildings and other long-lived assets charged against each year they are used. Depreciation and amortisation in the glossary | 5 | 7 | 7 | 7 | 7 | 8 | 8 | – | 7 | 8 | 7 | – | 7 | – | 7 | 7 | 7 | 9 | 7 | 8 |
| Other incomeOther income. Income from outside the main business, such as interest on deposits, dividends received and gains on investments. Other income in the glossary | 2 | 1 | 2 | 1 | 2 | 2 | 2 | 2 | 5 | 7 | 5 | – | 0 | 5 | 2 | 12 | −4 | 8 | 1 | 1 |
| Finance costsFinance costs. Interest and the other costs of borrowing in the period. Finance costs in the glossary | 14 | 14 | 15 | 19 | 17 | 19 | 20 | 22 | 23 | 24 | 28 | – | 44 | 34 | 43 | 66 | 118 | 20 | 35 | 22 |
| Profit before one-off items and taxProfit before one-off items and tax. Profit before tax as it would be without the one-off items below it, as the company states it. Profit before one-off items and tax in the glossary | 23 | 23 | 24 | 23 | 30 | 30 | 30 | 24 | 30 | 36 | 25 | – | 7 | 5 | −21 | −75 | −270 | −47 | −73 | −51 |
| One-off itemsExceptional items. Gains or losses the company reports separately because they are not expected to recur, such as selling a business or writing down an asset. Exceptional items in the glossary | −1 | −1 | −1 | −1 | −1 | −1 | −2 | −2 | −2 | −3 | – | – | – | – | – | – | 380 | – | – | – |
| Profit before tax | 22 | 22 | 22 | 22 | 29 | 29 | 28 | 22 | 27 | 34 | 25 | – | 7 | 5 | −21 | −75 | 110 | −47 | −73 | −51 |
| Tax | 3 | 6 | 4 | 4 | 5 | 6 | 6 | 5 | 6 | 7 | 5 | – | 0 | 1 | – | – | 1 | – | – | – |
| Tax rateEffective tax rate. Tax charged as a percentage of profit before tax. Effective tax rate in the glossary | 13.7% | 26.3% | 19.0% | 16.1% | 18.5% | 21.7% | 19.5% | 21.1% | 20.1% | 20.0% | 20.3% | – | −0.5% | 20.1% | – | – | 0.6% | – | – | – |
| Net profit | 19 | 16 | 18 | 18 | 23 | 22 | 23 | 17 | 22 | 27 | 20 | – | 7 | 4 | −21 | −75 | 109 | −47 | −73 | −51 |
| Net margin | 9.9% | 7.9% | 8.6% | 8.2% | 10.5% | 8.8% | 8.8% | 7.0% | 8.4% | 8.9% | 7.8% | – | 3.6% | 2.5% | −15.5% | −74.0% | 120.1% | −55.8% | −205.3% | −210.0% |
| Earnings per share | – | – | – | – | – | ₹10.90 | – | ₹8.34 | – | ₹13.16 | ₹9.58 | – | – | – | −₹10.41 | −₹36.66 | – | −₹22.85 | −₹35.54 | −₹24.93 |
Earnings per share in rupees, restated for later splits and bonuses. No results on record for the quarter to Mar 2013.
7 years at a glance
Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March, then June.
Revenue, net profit and borrowings, ₹ crore
- Revenue
- Net profit
- Borrowings
Operating and net margin, per cent
- Operating marginOperating margin. Operating profit before depreciation as a percentage of revenue: how much of each rupee of sales is left after running costs. Operating margin in the glossary
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
The company moved its year end from March to June: its last year to March on record ended in Mar 2012, its first year to June in Jun 2014.
The years either side of a change of basis do not compare. From the year to Mar 2009, the company's revenue for that year, ₹620 Cr, differs from its quarters added, ₹609 Cr.
Results for the year to Jun 2014
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
From revenue to net profit
- Revenue483
- Materials and goods−308
- Employee costs−116
- Other expenses−147
- Operating profit−88
- Depreciation−29
- Other income+15
- One-off items+380
- Finance costs−260
- Profit before tax18
- Tax−0.7
- Net profit17
Profit and loss
Standalone, ₹ crore, years to March, then June. No results on record for the year to Jun 2013. The last column is the twelve months to Mar 2015, the latest four quarters added.
| ₹ crore | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 | Jun 2014 | Mar 2015Twelve months |
|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 548 | 620 | 703 | 832 | 985 | – | 483 | 235 |
| 438 | 519 | 573 | 661 | – | – | 572 | 457 | |
| Materials and goods bought | 255 | 302 | 331 | 376 | 471 | – | 308 | 276 |
| Employee costs | – | 87 | 94 | 109 | – | – | 116 | 77 |
| Other expenses | – | 131 | 148 | 176 | – | – | 147 | 104 |
| Operating profit before depreciation | 110 | 101 | 129 | 172 | – | – | −88 | −222 |
| Operating margin | 20.2% | 16.3% | 18.4% | 20.6% | – | – | −18.2% | −94.5% |
| Materials, % of revenueMaterials, % of revenue. Raw materials used and goods bought for resale, adjusted for the change in stock, divided by revenue, times 100. Materials, % of revenue in the glossary | – | 48.6% | 47.1% | 45.2% | – | – | 63.8% | 117.4% |
| Employee costs, % of revenueEmployee costs, % of revenue. Salaries, wages and other staff costs divided by revenue, times 100. Employee costs, % of revenue in the glossary | – | 14.0% | 13.4% | 13.1% | – | – | 24.1% | 33.0% |
| Other expenses, % of revenueOther expenses, % of revenue. Operating costs besides materials and staff divided by revenue, times 100; with the two above and the operating margin it makes 100. Other expenses, % of revenue in the glossary | – | 21.1% | 21.1% | 21.1% | – | – | 30.4% | 44.1% |
| Depreciation and amortisation | 13 | 12 | 17 | 27 | – | – | 29 | 31 |
| Operating profit after depreciationOperating profit after depreciation (EBIT). Operating profit before depreciation, less depreciation and amortisation. Operating profit after depreciation (EBIT) in the glossary | 98 | 89 | 113 | 145 | – | – | −117 | −253 |
| Other income | 4 | 8 | 8 | 8 | 24 | – | 15 | 6 |
| Finance costs | 19 | 37 | 51 | 59 | 89 | – | 260 | 195 |
| Profit before one-off items and tax | – | 60 | 69 | 94 | 110 | – | −362 | −441 |
| One-off items | – | −1 | −5 | −5 | −6 | – | 380 | – |
| Profit before tax | 83 | 59 | 65 | 89 | 104 | – | 18 | −61 |
| Tax | 11 | 8 | 9 | 18 | 19 | – | 1 | – |
| Net profit | 72 | 51 | 55 | 71 | 84 | – | 17 | −62 |
| Net margin | 13.1% | 8.2% | 7.9% | 8.6% | 8.5% | – | 3.6% | −26.4% |
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2008 they do not, so they are left blank. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2012: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given.
Ratios
Standalone, years to March, then June.
| Ratio | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 | Jun 2014 |
|---|---|---|---|---|---|---|---|
| Revenue growthRevenue growth. This year's revenue less last year's, divided by last year's, times 100; blank where last year's is not above nought. Revenue growth in the glossary | – | – | 13.3% | 18.4% | 18.3% | – | – |
| Operating profit growthOperating profit growth. This year's operating profit before depreciation less last year's, divided by last year's, times 100; blank where last year's is not above nought. Operating profit growth in the glossary | – | – | 28.3% | 32.8% | – | – | – |
| Net profit growthNet profit growth. This year's net profit less last year's, divided by last year's, times 100; blank where last year's is not above nought. Net profit growth in the glossary | – | – | 9.4% | 28.9% | 17.9% | – | – |
| Interest coverInterest cover. Operating profit after depreciation divided by finance costs: how many times over the profit pays the interest bill. Interest cover in the glossary | 5.1 | 2.4 | 2.2 | 2.4 | – | – | – |
Revenue growth, operating profit growth and net profit growth are left blank for the year to Mar 2009: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out. Interest cover is left blank for the year to Jun 2014: operating profit after depreciation is a loss, and a loss covers no interest bill.
Accounting checks
Standalone, years to March, then June. Published tests of whether reported profit is backed by cash and the balance sheet.
| Check | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 | Jun 2014 |
|---|---|---|---|---|---|---|---|
| Effective tax ratePublished threshold 17.16 per cent | 13.28 | 13.56 | 14.36 | 19.84 | 18.70 | – | 3.76 |
A threshold marked as ours has no published figure; it is the line we read the check against.
Where the return came from
Yearly rates to Jun 2014, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −33.3% | – | – | 0.0% |
| 3 years | −17.4% | – | – | 0.0% |
| 5 years | −1.9% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.
Elder Pharmaceuticals share price by year
Each calendar year to 2016.
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2016 | 38.00 | −49.5% | 78.15 | 21.40 |
| 2015 | 75.30 | −27.7% | 162.85 | 68.30 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The 2016 close is its last trade, on 12 Sep 2016.
Recent sessions
The 10 trading days to 12 Sep 2016, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 12 Sep 2016 | 38.00 | 38.00 | 38.00 | 38.00 | 38.00 | 4,600 |
| 6 Sep 2016 | 34.50 | 36.20 | 32.80 | 36.20 | 35.45 | 17,537 |
| 29 Aug 2016 | 33.00 | 34.50 | 33.00 | 34.50 | 34.48 | 5,274 |
| 22 Aug 2016 | 32.80 | 32.90 | 32.05 | 32.90 | 32.69 | 3,905 |
| 16 Aug 2016 | 31.35 | 31.35 | 29.90 | 31.35 | 31.34 | 4,215 |
| 8 Aug 2016 | 29.90 | 29.90 | 29.90 | 29.90 | 29.90 | 2,474 |
| 1 Aug 2016 | 28.50 | 28.50 | 28.50 | 28.50 | 28.50 | 1,590 |
| 25 Jul 2016 | 27.15 | 27.15 | 27.15 | 27.15 | 27.15 | 3,044 |
| 18 Jul 2016 | 25.90 | 25.90 | 25.90 | 25.90 | 25.90 | 4,829 |
| 11 Jul 2016 | 24.70 | 24.70 | 24.70 | 24.70 | 24.70 | 356 |
Prices in ₹ per share as traded, not adjusted.
Company details
- BSE code
- 532322
- ISIN
- INE975A01015
- Former symbols
- ELDERPHARM
- Website
- www.elderindia.com
- CIN
- L24239MH1983PLC029714
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1983
- Registered office
- Elder House, Plot No C-9 Dalia Industrial Estate Off Veera Desai Road Andheri ( W), Mumbai 400053, Maharashtra
- Share registrar
- Link Intime India Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments